France's Abivax UC Drug Phase III Positive with Safety Signal, Stock Plunges on June 2
French biotech company Abivax (Euronext Paris and Nasdaq: ABVX) saw its stock price experience sharp...
Ractigen Therapeutics' saRNA Reduces Fat by 45%, Accepted for ADA 2026 Poster Presentation
Ractigen Therapeutics announced that the latest research abstract on its first-in-class small activa...
Everest Medicines Acquires Rights to Develop, Manufacture, and Commercialize Presbyopia Treatment Eye Drops LNZ100 in Greater China
Everest Medicines (HKEX 1952.HK) announced that it has entered into an asset purchase agreement with...
EBGMP Evaluation Model Construction Fills Gap in Inspector Perspective
An evidence-based evaluation model for GMP inspectors (EBGMP, Evidence-based GMP) has been developed...
MannKind Showcases New Afrezza Pediatric Data at ADA
MannKind Corporation will present new clinical and real-world data on its products Afrezza (human in...
Chinese Study: Ecnoglutide Outperforms Semaglutide in Weight Loss by 35%
Sciwind Biosciences announced interim analysis results from its head-to-head study (SLIMMER-UP-SWITC...
Danish Zealand Pharma's Partner Drug Phase III Trial: Visceral Fat Reduced by 34%, Liver Fat by 63%
On June 7, Zealand Pharma announced that its partner Boehringer Ingelheim's glucagon/GLP-1 dual agon...
Amgen Reports New Results from Evolocumab Trial in the US: 25% Risk Reduction in Primary Endpoint
Amgen announced new overall and subgroup results from the Phase 3 VESALIUS-CV trial of Repatha (evol...
Germany's healthcare cost-cutting plan leads to 50% reduction in Eli Lilly's investment and Boehringer Ingelheim's suspension of €900 million project
Germany's federal government healthcare cost-cutting plan is having a direct impact on large pharmac...
Curium invests €32 million in France to build a prostate cancer radiopharmaceutical production line
Curium, a global leader in nuclear medicine, announced at the "Choose France" summit held in Versail...
Rakovina's R&D Spending Rises to 70% of Operating Expenses in Q1
Rakovina Therapeutics Inc. (RKV:TSX.V) reported its first-quarter financial results for the period e...
Altesa ASM Conference Presents Vapendavir Phase 2a Study
Altesa BioSciences announced clinical study results showing that its oral investigational rhinovirus...
US Cloudbreak's Phase III Pterygium Drug Completes Final Visit
Cloudbreak Pharma Inc. (Hong Kong Stock Exchange Code: 2592) announced that the Phase III clinical t...
Mabwell's 9MW5211 Receives NMPA Clinical Trial Approval for IBD in China
Shanghai, June 4, 2026 — Mabwell (688062.SH, 02493.HK) announced that its independently developed in...
Tunisia Achieves Local Production of Key Radiopharmaceutical for Prostate Cancer
With support from the International Atomic Energy Agency (IAEA), Tunisia has achieved local producti...
AstraZeneca liver cancer combination therapy reduces risk of progression or death by 30%
Results from AstraZeneca's Phase III Emerald-3 trial showed that the regimen of durvalumab combined ...
Novartis's Secukinumab Phase III Trial Shows Sustained Remission Rate Twice That of Placebo
Novartis has announced new data from the Phase III REPLENISH trial evaluating Cosentyx (secukinumab)...
UK's Elementis Completes Sale of Pharmaceutical Manufacturing Business for €34.3 Million
Elementis plc has announced the completion of the sale of its pharmaceutical manufacturing business ...
U.S. Study: GLP-1 Drug Users See 35% Lower Breast Cancer Diagnosis Rate
An observational study led by Elizabeth McDonald, a professor of radiology at the Perelman School of...
Johnson & Johnson Releases Nipocalimab Data for Sjögren's Syndrome, Response Rate Reaches 62.5% in High Autoantibody Subgroup
On June 3, Johnson & Johnson announced new exploratory biomarker analyses from the Phase 2 DAHLI...
Brazil's Medical Cannabis Imports Hit Record High in March 2026, Up 60.1%
In March 2026, Brazil's medical cannabis imports reached a record high, with 23,199 import authoriza...
Germany's FundaMental Pharma Appoints Chief Medical Officer
FundaMental Pharma GmbH announced the appointment of Dr. Hans Eriksson as Chief Medical Officer, whe...
Mikron Automation Switzerland Provides Scalable Assembly Solutions for Pharmaceutical and Medical Devices
Mikron Automation, part of the Mikron Group, offers advanced assembly solutions for pharmaceutical a...
US-based RayzeBio Plans $150 Million Investment in Radiopharmaceutical Facility
On June 1, RayzeBio, a subsidiary of Bristol Myers Squibb, announced plans to invest approximately $...
Zhejiang, China Launches 225Ac-PSMA Clinical Study for Prostate Cancer and Completes First Patient Dosing
The Department of Nuclear Medicine at Zhejiang Cancer Hospital recently initiated an international m...
Eli Lilly Launches LillyPod Supercomputer, AI Drug Discovery Enters Era of Pharma-Built Computing Power
In October 2025, Eli Lilly announced plans to build the most powerful supercomputer in the pharmaceu...
SHINE Technologies' Ilumira Lu-177 Receives EU Centralized Marketing Authorization
SHINE Technologies' non-carrier-added lutetium-177 (Lu-177) product, Ilumira, has received a Central...
Novo Nordisk's Wegovy Oral Drug Receives Positive European Review, Plans to Launch in Spain
The European Medicines Agency has issued a positive review for the oral therapy Wegovy (semaglutide)...
The Third Annual Academic Conference of the Beijing Medical Association Nuclear Medicine Specialist Branch in 2026 Convened
The Third Annual Academic Conference of the Beijing Medical Association Nuclear Medicine Specialist ...
Australia's Telix Announces Phase 3 Data for TLX591-Tx at ASCO 2026
Telix Pharmaceuticals Limited presented safety, dosimetry, and pharmacokinetic data from the first p...